(R)-tert-Butyl 1-(2-nitrophenyl)pyrrolidine-3-ylcarbamate

Catalog No. :
ACUNLT828
CAS No. :
1029432-34-5
Molecular Formula :
C15H21N3O4
Molecular Weight :
307.35

IUPAC Name:tert-butyl (R)-(1-(2-nitrophenyl)pyrrolidin-3-yl)carbamate

(R)-tert-Butyl 1-(2-nitrophenyl)pyrrolidine-3-ylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg99%$8516.00Login to see priceIn stockInquiry
250mg99%$17031.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 1-(2-nitrophenyl)pyrrolidine-3-ylcarbamate
IUPAC Nametert-butyl (R)-(1-(2-nitrophenyl)pyrrolidin-3-yl)carbamate
MDL No.MFCD11041692
Molecular FormulaC15H21N3O4
Molecular Weight307.35
SMILESO=C(OC(C)(C)C)N[C@H]1CN(C2=CC=CC=C2[N+]([O-])=O)CC1
InChI KeyASGSCQCZBVODJB-LLVKDONJSA-N
Synonym(R)-tert-Butyl 1-(2-nitrophenyl)pyrrolidine-3-ylcarbamate;Carbamic acid, N-[(3R)-1-(2-nitrophenyl)-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1029432-34-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUNLT828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUNLT828 route product structure diagram
    ACUNLT8281029432-34-5 In Stock
Inquiry

2. ACUNLT828 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUNLT828 route product structure diagram
    ACUNLT8281029432-34-5 In Stock
Inquiry

Comments (0)